Search

Your search keyword '"Castelli, Joel"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Castelli, Joel" Remove constraint Author: "Castelli, Joel"
107 results on '"Castelli, Joel"'

Search Results

2. Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study

6. Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial

7. Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CT

8. Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

11. Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view

13. Head and neck tumor segmentation in PET/CT: The HECKTOR challenge

16. Fully Automatic Head and Neck Cancer Prognosis Prediction in PET/CT

17. Multi-task Deep Segmentation and Radiomics for Automatic Prognosis in Head and Neck Cancer

18. Overview of the HECKTOR Challenge at MICCAI 2020: Automatic Head and Neck Tumor Segmentation in PET/CT

19. Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

20. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

21. Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study

36. 18F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer

37. P-177 FDG-PET/CT-based prognostic survival model after surgery for head and neck cancer

38. Statistical harmonization can improve the development of a multicenter CT‐based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers

42. Development and validation of a PET-based nomogram predictive for survival of oropharyngeal cancer patients

43. Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy

46. Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis

47. The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning

50. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia

Catalog

Books, media, physical & digital resources